Novel therapeutic targets for Parkinson’s disease: an interview with Patrik Brundin

Written by Sharon Salt, Editor

Patrik Brundin (MD, PhD) is originally from Sweden and has spent around 30 years at Lund University (Sweden). Currently, he is the Director of the Center for Neurodegenerative Science at the Van Andel Institute (MI, USA). Patrik is also one of the top cited researchers in the field of neuroscience with more than 300 publications on Parkinson’s’ disease and related topics. In this interview, Patrik speaks to us about what inspired him to work in in the Parkinson’s research field. He also tells us more about his talk on novel therapeutic targets for Parkinson’s disease and how he’s extremely optimistic...

To view this content, please register now for access

It's completely free